HCPCS Level II
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
Codes near J9217
These sit next to J9217 in the CMS Level II file. All J codes
- J9212Injection, interferon alfacon-1, recombinant, 1 microgram
- J9213Injection, interferon, alfa-2a, recombinant, 3 million units
- J9214Injection, interferon, alfa-2b, recombinant, 1 million units
- J9215Injection, interferon, alfa-n3, (human leukocyte derived), 250, 000 iu
- J9216Injection, interferon, gamma 1-b, 3 million units
- J9218Leuprolide acetate, per 1 mg
- J9219Leuprolide acetate implant, 65 mg
- J9220Injection, indigotindisulfonate sodium, 1 mg
- J9223Injection, lurbinectedin, 0.1 mg
- J9225Histrelin implant (vantas), 50 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00074-3346-03 | Lupron Depot | AbbVie Inc. | 3 |
| 00074-3346-55 | Lupron Depot | AbbVie Inc. | 3 |
| 00074-3473-03 | Lupron Depot | AbbVie Inc. | 6 |
| 00074-3473-55 | Lupron Depot | AbbVie Inc. | 6 |
| 00074-3642-03 | Lupron Depot | AbbVie Inc. | 1 |
| 00074-3642-55 | Lupron Depot | AbbVie Inc. | 1 |
| 00074-3683-03 | Lupron Depot | AbbVie Inc. | 4 |
| 00074-3683-55 | Lupron Depot | AbbVie Inc. | 4 |
| 62935-0223-05 | Eligard | Tolmar Inc. | 3 |
| 62935-0227-10 | Eligard | Tolmar Inc. | 3 |
| 62935-0303-30 | Eligard | Tolmar Inc. | 4 |
| 62935-0306-40 | Eligard | Tolmar Inc. | 4 |
| 62935-0453-45 | Eligard | Tolmar Inc. | 6 |
| 62935-0461-50 | Eligard | Tolmar Inc. | 6 |
| 62935-0753-75 | Eligard | Tolmar Inc. | 1 |
| 62935-0756-80 | Eligard | Tolmar Inc. | 1 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.